Compare SWKS & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SWKS | BIO |
|---|---|---|
| Founded | 1962 | 1952 |
| Country | United States | United States |
| Employees | N/A | 7450 |
| Industry | Semiconductors | Biotechnology: Laboratory Analytical Instruments |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.0B | 7.1B |
| IPO Year | 1995 | N/A |
| Metric | SWKS | BIO |
|---|---|---|
| Price | $53.87 | $269.42 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 15 | 4 |
| Target Price | $72.85 | ★ $358.50 |
| AVG Volume (30 Days) | ★ 2.5M | 241.0K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 5.20% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.53 | N/A |
| Revenue | ★ $4,086,900,000.00 | N/A |
| Revenue This Year | N/A | $2.51 |
| Revenue Next Year | $2.85 | $3.17 |
| P/E Ratio | $102.98 | ★ $9.72 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $47.93 | $211.43 |
| 52 Week High | $90.90 | $343.12 |
| Indicator | SWKS | BIO |
|---|---|---|
| Relative Strength Index (RSI) | 29.57 | 43.72 |
| Support Level | $53.21 | $266.71 |
| Resistance Level | $61.80 | $289.61 |
| Average True Range (ATR) | 1.90 | 7.99 |
| MACD | -0.33 | 0.10 |
| Stochastic Oscillator | 15.95 | 35.33 |
Skyworks Solutions produces semiconductors for wireless handsets and other devices that are used to enable wireless connectivity. Its main products include power amplifiers, filters, switches, and integrated front-end modules that support wireless transmissions. Skyworks' customers are mostly large smartphone manufacturers, but the firm also has a growing presence in nonhandset applications such as wireless routers, medical devices, and automobiles.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.